Back to search
FDAFDA · Food and drugs·Recall number D-0168-2025

Nitrofurantoin Capsules, USP, 100 mg, 50 Capsules (5 x 10) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478. NDC#: 50268-625-15.

Published January 8, 2025 · Recall initiated: December 4, 2024

Summary

FDA records drug Class II recall D-0168-2025, published January 8, 2025 and initiated December 4, 2024. Recalling firm: AvKARE; Status: Ongoing; Reported quantity: 1016 50-count cartons; Lot: Lot # 47101; Exp. 02/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
AvKARE
Distributor
Nationwide USA
Lot
Lot # 47101; Exp. 02/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Nitrofurantoin Capsules, USP, 100 mg, 50 Capsules (5 x 10) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478. NDC#: 50268-625-15. recalled?

Yes. FDA published recall D-0168-2025 on January 8, 2025. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter